Javascript verkar inte påslaget? - Vissa delar av Lunds universitets webbplats fungerar inte optimalt utan javascript, kontrollera din webbläsares inställningar.
Du är här

Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information?

Publiceringsår: 2012
Språk: Engelska
Sidor: 343-345
Publikation/Tidskrift/Serie: Proteomics Clinical Applications
Volym: 6
Nummer: 7-8
Dokumenttyp: Artikel i tidskrift
Förlag: John Wiley & Sons


Proteomics has not delivered biomarkers of clinical value, despite massive efforts. The technologies that are emerging today have, however, the power to reach deep into proteomes and to identify patterns associated with different diseases. The study design is then crucial and sample quality, bioinformatic approaches, pre-validation, using independent patient cohort, need to attract increased attention before proteomics will contribute to the needs of personalized medicine.


  • Cell and Molecular Biology
  • over-fitting
  • biobanks
  • pre-validation
  • bioinformatics
  • Signatures


  • ISSN: 1862-8354

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen